NCAM1 and neuroendocrine neoplasm: Although high-grade neuroendocrine neoplasms were more likely to express polySia-NCAM compared to carcinoids, our small pilot study showed no significant correlation between polySia-NCAM expression and clinical characteristics or radiologically determined disease progression.